Helus Pharma Inc. balance sheet

Helus Pharma Inc.'s balance sheet by fiscal year.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Helus Pharma Inc.: balance sheet, annual
Fiscal year	2021Mar 2021	2022Mar 2022
Cash and equivalents	51	43
Net debt (negative = net cash)	−51	−43

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Helus Pharma Inc.'s SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Helus Pharma Inc.